Down with opacity and shady deals!

Anne PlestedFollowing the MiFID II roadmap a significant milestone was reached in Brussels last week with the final text of EMIR (European Market Infrastructure Regulation) agreed on 9th February.

After 2 years of European Parliament debate this will bring to an end “the era of opacity and shady deals”, according to Michel Bernier the EU commissioner!

EMIR is one part of the history-making global effort to reduce systemic risk, through increased transparency of the OTC derivatives market and re-engineering of the infrastructure.

This will bring Europe closer to meeting the G20 commitment by the end of 2012: “all standardised OTC derivatives contracts should be traded on exchanges or electronic platforms, where appropriate, and cleared through central counterparties by end-2012 at the latest …”.

EMIR obligations apply to financial institutions and to industrial companies dealing in derivatives, with rules covering OTC derivative transactions, central counterparties (CCP) and trade repositories. The US equivalent to EMIR is the Dodd-Frank Act (aka Title VII), the rules of which are expected to be completed in Q2/Q3 2012.

According to the FSA – The Regulation introduces:

  • a reporting obligation for OTC derivatives
  • a clearing obligation for eligible OTC derivatives
  • measures to reduce counterparty credit risk and operational risk for bilaterally cleared OTC derivatives
  • common rules for CCPs and for trade repositories
  • rules on the establishment of interoperability between CCPs

The next step is for ESMA to complete the development of the EMIR implementation details by the end of September this year. EMIR is expected to come into force during 2012; existing CCPs will have 2 years from that date to apply for recognition and trade repositories will have to apply for recognition during 2012.

Leave A Comment

Copyright © 2019 Fidessa Group Holdings Limited. All rights reserved.

The information contained within this website is provided for informational purposes only. Fidessa will use reasonable care to ensure that information is accurate at the time it is made available, and for the duration that it remains on the site. The information may be changed by Fidessa at any time without notice. We also reserve the right to close the website at any time. No representation or warranty, expressed or implied, is given on behalf of Fidessa or any of its respective directors, employees, agents, or advisers as to the accuracy or completeness of the information or opinions contained herein or its suitability for any purpose and, save in the case of fraud, all liability for direct, indirect, special, consequential or other loss or damages of whatever kind that may arise from use of the website is hereby excluded to the fullest extent permitted by law. Any decisions you make based on the information in this website are your sole responsibility and information on the website should not be relied upon in connection with any investment decision.

The copyright of this website belongs to Fidessa. All other intellectual property rights are reserved.

Reproduction or redistribution of this information is prohibited except with written permission from Fidessa.